Articoli di riviste sul tema "MET/HGF"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "MET/HGF".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Toiyama, Y., K. Tanaka, H. Yasuda, S. Saigusa, H. Fujikawa, Y. Mohri, Y. Inoue, C. Miki, T. Tabata e M. Kusunoki. "Use of co-expression of HGF and c-Met to predict peritoneal dissemination established by autocrine HGF/c-Met signaling in gastric cancer." Journal of Clinical Oncology 29, n. 4_suppl (1 febbraio 2011): 40. http://dx.doi.org/10.1200/jco.2011.29.4_suppl.40.
Zhang, Hongli, Qingqing Feng, Wei-Dong Chen e Yan-Dong Wang. "HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers". International Journal of Molecular Sciences 19, n. 11 (23 ottobre 2018): 3295. http://dx.doi.org/10.3390/ijms19113295.
Weimar, Iris S., Daphne de Jong, Egbert J. Muller, Toshikazu Nakamura, Joost M.H.H. van Gorp, Gijsbert C. de Gast e Winald R. Gerritsen. "Hepatocyte Growth Factor/Scatter Factor Promotes Adhesion of Lymphoma Cells to Extracellular Matrix Molecules Via α4β1 and α5β1 Integrins". Blood 89, n. 3 (1 febbraio 1997): 990–1000. http://dx.doi.org/10.1182/blood.v89.3.990.
Gallo, Simona, Valentina Sala, Stefano Gatti e Tiziana Crepaldi. "Cellular and molecular mechanisms of HGF/Met in the cardiovascular system". Clinical Science 129, n. 12 (11 novembre 2015): 1173–93. http://dx.doi.org/10.1042/cs20150502.
De Silva, Dinuka M., Arpita Roy, Takashi Kato, Fabiola Cecchi, Young H. Lee, Kunio Matsumoto e Donald P. Bottaro. "Targeting the hepatocyte growth factor/Met pathway in cancer". Biochemical Society Transactions 45, n. 4 (3 luglio 2017): 855–70. http://dx.doi.org/10.1042/bst20160132.
Kauma, Scott, Natalie Hayes e Shannon Weatherford. "The Differential Expression of Hepatocyte Growth Factor and Met in Human Placenta*". Journal of Clinical Endocrinology & Metabolism 82, n. 3 (1 marzo 1997): 949–54. http://dx.doi.org/10.1210/jcem.82.3.3806.
Yamasaki, Koji, Shoichiro Mukai, Takahiro Nagai, Kozue Nakahara, Masato Fujii, Naoki Terada, Akinobu Ohno et al. "Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis". International Journal of Molecular Sciences 19, n. 12 (22 novembre 2018): 3708. http://dx.doi.org/10.3390/ijms19123708.
Woolf, A. S., M. Kolatsi-Joannou, P. Hardman, E. Andermarcher, C. Moorby, L. G. Fine, P. S. Jat, M. D. Noble e E. Gherardi. "Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros." Journal of Cell Biology 128, n. 1 (1 gennaio 1995): 171–84. http://dx.doi.org/10.1083/jcb.128.1.171.
Tanaka, Ryota, Mizue Terai, Eric Londin e Takami Sato. "The Role of HGF/MET Signaling in Metastatic Uveal Melanoma". Cancers 13, n. 21 (30 ottobre 2021): 5457. http://dx.doi.org/10.3390/cancers13215457.
Czyz, Malgorzata. "HGF/c-MET Signaling in Melanocytes and Melanoma". International Journal of Molecular Sciences 19, n. 12 (3 dicembre 2018): 3844. http://dx.doi.org/10.3390/ijms19123844.
Kumar, Vinod, Zachary A. Yochum, Princey Devadassan, Eric Huang, Ethan Miller, Vasavi Ayyala, Laura P. Stabile, Timothy F. Burns e Purva H. Rumde. "Abstract 1091: TWIST1 inhibition overcomes resistance to tyrosine kinase inhibitors in MET driven non-small cell lung cancer". Cancer Research 82, n. 12_Supplement (15 giugno 2022): 1091. http://dx.doi.org/10.1158/1538-7445.am2022-1091.
Sato, Hiroki, Ryu Imamura, Hiroaki Suga, Kunio Matsumoto e Katsuya Sakai. "Cyclic Peptide-Based Biologics Regulating HGF-MET". International Journal of Molecular Sciences 21, n. 21 (27 ottobre 2020): 7977. http://dx.doi.org/10.3390/ijms21217977.
Kentsis, Alex, Takaomi Sanda, Vu Ngo, Scott J. Rodig, Jeffery Kutok, Eleni Tholouli, Richard Byers et al. "Aberrant Expression of Hepatocyte Growth Factor Induces Autocrine MET Activation Providing a Novel Therapeutic Target In Acute Myeloid Leukemia." Blood 116, n. 21 (19 novembre 2010): 1042. http://dx.doi.org/10.1182/blood.v116.21.1042.1042.
McInnis, Ian, Theresa Hahn, Anasitasia Ioane, Ashleigh Lamson, Deepika Lal, Laurie Ann Ford, Sheila NJ Sait et al. "Diverse Roles of Hepatocyte Growth Factor (HGF) in Normal Karyotype Acute Myeloid Leukemia (AML)." Blood 114, n. 22 (20 novembre 2009): 3107. http://dx.doi.org/10.1182/blood.v114.22.3107.3107.
Zhou, Si-Rui, Wen-Ting Yuan, Xiao-Yan Pan, Tong Wang e Xiao-Dong Chen. "Hepatocyte growth factor promotes retinal pigment epithelium cell activity through MET/AKT signaling pathway". International Journal of Ophthalmology 17, n. 5 (18 maggio 2024): 806–14. http://dx.doi.org/10.18240/ijo.2024.05.03.
Borset, M., H. Hjorth-Hansen, C. Seidel, A. Sundan e A. Waage. "Hepatocyte growth factor and its receptor c-met in multiple myeloma". Blood 88, n. 10 (15 novembre 1996): 3998–4004. http://dx.doi.org/10.1182/blood.v88.10.3998.bloodjournal88103998.
Anastasi, Sergio, Silvia Giordano, Olga Sthandier, Giovanna Gambarotta, Rossella Maione, Paolo Comoglio e Paolo Amati. "A Natural Hepatocyte Growth Factor/Scatter Factor Autocrine Loop in Myoblast Cells and the Effect of the Constitutive Met Kinase Activation on Myogenic Differentiation". Journal of Cell Biology 137, n. 5 (2 giugno 1997): 1057–68. http://dx.doi.org/10.1083/jcb.137.5.1057.
Tahira, Yumiko, Katsuya Sakai, Hiroki Sato, Ryu Imamura e Kunio Matsumoto. "Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation". International Journal of Molecular Sciences 22, n. 17 (26 agosto 2021): 9240. http://dx.doi.org/10.3390/ijms22179240.
Chang, Chih-Ching, Jia-Jhen Chiu, Shan-Ling Chen, Hui-Chun Huang, Hui-Fen Chiu, Bo-Huei Lin e Chun-Yuh Yang. "Activation of HGF/c-Met signaling by ultrafine carbon particles and its contribution to alveolar type II cell proliferation". American Journal of Physiology-Lung Cellular and Molecular Physiology 302, n. 8 (15 aprile 2012): L755—L763. http://dx.doi.org/10.1152/ajplung.00350.2011.
Dedov, I. I., Ye A. Troshina, N. V. Mazurina e A. Belfiore. "Low expression of Met-hepatocytic growth factor receptor as an indicator of poor prognosis in thyroid tumors". Problems of Endocrinology 47, n. 3 (15 giugno 2001): 6–10. http://dx.doi.org/10.14341/probl11467.
You, Jingjing, Li Wen, Athena Roufas, Chris Hodge, Gerard Sutton e Michele C. Madigan. "Expression of HGF and c-Met Proteins in Human Keratoconus Corneas". Journal of Ophthalmology 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/852986.
Blanquaert, Frederic, Renata C. Pereira e Ernesto Canalis. "Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts". American Journal of Physiology-Endocrinology and Metabolism 278, n. 3 (1 marzo 2000): E509—E515. http://dx.doi.org/10.1152/ajpendo.2000.278.3.e509.
Boschert, Verena, Nicola Klenk, Alexander Abt, Sudha Janaki Raman, Markus Fischer, Roman C. Brands, Axel Seher et al. "The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma". International Journal of Molecular Sciences 21, n. 2 (11 gennaio 2020): 471. http://dx.doi.org/10.3390/ijms21020471.
Cao, Tong, Jing Pan, Xiulian Li, Yanli He, Yifei Jiang, Yajing Chang, Qi Zhang et al. "Isolation and Characterization of a Chinese Hamster Ovary Heparan Sulfate Cell Mutant Defective in Both Met Receptor Binding and Hepatocyte Growth Factor NK1/Met Signaling". Cellular Physiology and Biochemistry 48, n. 4 (2018): 1480–91. http://dx.doi.org/10.1159/000492258.
Beilmann, Mario, George F. Vande Woude, Hans-Peter Dienes e Peter Schirmacher. "Hepatocyte growth factor–stimulated invasiveness of monocytes". Blood 95, n. 12 (15 giugno 2000): 3964–69. http://dx.doi.org/10.1182/blood.v95.12.3964.
Beilmann, Mario, George F. Vande Woude, Hans-Peter Dienes e Peter Schirmacher. "Hepatocyte growth factor–stimulated invasiveness of monocytes". Blood 95, n. 12 (15 giugno 2000): 3964–69. http://dx.doi.org/10.1182/blood.v95.12.3964.012k20_3964_3969.
Hay, Rick V., Brian Cao, R. Scot Skinner, Ling-Mei Wang, Yanli Su, James H. Resau, George F. Vande Woude e Milton D. Gross. "Radioimmunoscintigraphy of Tumors Autocrine for Human Met and Hepatocyte Growth Factor/Scatter Factor". Molecular Imaging 1, n. 1 (1 gennaio 2002): 153535002002000. http://dx.doi.org/10.1162/15353500200200006.
Tonomura, Hitoshi, Masateru Nagae, Ryota Takatori, Hidenobu Ishibashi, Tomonori Itsuji e Kenji Takahashi. "The Potential Role of Hepatocyte Growth Factor in Degenerative Disorders of the Synovial Joint and Spine". International Journal of Molecular Sciences 21, n. 22 (18 novembre 2020): 8717. http://dx.doi.org/10.3390/ijms21228717.
Xu, Chuanhui, Anke Van Den Berg, Wouter Plattel, Nele Ruther, Huang Xin, Miao Wang, Gustaaf Van Imhoff et al. "Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma". Blood 116, n. 21 (19 novembre 2010): 3880. http://dx.doi.org/10.1182/blood.v116.21.3880.3880.
Sweis, Randy F., Petros Grivas, Alexander T. Pearson, Kathleen C. Day, Mark L. Day e Maha Hussain. "Expression of MET and HGF in bladder cancer tumorigenesis and invasion." Journal of Clinical Oncology 30, n. 15_suppl (20 maggio 2012): 4573. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.4573.
Beilmann, Mario, Margarete Odenthal, Waltraud Jung, George F. Vande Woude, Hans-Peter Dienes e Peter Schirmacher. "Neoexpression of the c-met/Hepatocyte Growth Factor-Scatter Factor Receptor Gene in Activated Monocytes". Blood 90, n. 11 (1 dicembre 1997): 4450–58. http://dx.doi.org/10.1182/blood.v90.11.4450.
Beilmann, Mario, Margarete Odenthal, Waltraud Jung, George F. Vande Woude, Hans-Peter Dienes e Peter Schirmacher. "Neoexpression of the c-met/Hepatocyte Growth Factor-Scatter Factor Receptor Gene in Activated Monocytes". Blood 90, n. 11 (1 dicembre 1997): 4450–58. http://dx.doi.org/10.1182/blood.v90.11.4450.4450_4450_4458.
Tjin, Esther P. M., Richard W. J. Groen, Irma Vogelzang, Patrick W. B. Derksen, Melanie D. Klok, Helen P. Meijer, Susanne van Eeden, Steven T. Pals e Marcel Spaargaren. "Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma". Blood 107, n. 2 (15 gennaio 2006): 760–68. http://dx.doi.org/10.1182/blood-2005-05-1929.
Sierra, J. Rafael, e Ming-Sound Tsao. "c-MET as a potential therapeutic target and biomarker in cancer". Therapeutic Advances in Medical Oncology 3, n. 1_suppl (novembre 2011): S21—S35. http://dx.doi.org/10.1177/1758834011422557.
Borset, Magne, Hakon Hov, Randi U. Holt, Torstein B. Ro, Unn-Merete Fagerli, Henrik Hjorth-Hansen, Vadim Baykov, James G. Christensen, Anders Waage e Anders Sundan. "A Selective Inhibitor of c-Met Blocks an Autocrine HGF Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma Cells." Blood 104, n. 11 (16 novembre 2004): 2358. http://dx.doi.org/10.1182/blood.v104.11.2358.2358.
Cerqua, Marina, Orsola Botti, Maddalena Arigoni, Noemi Gioelli, Guido Serini, Raffaele Calogero, Carla Boccaccio, Paolo M. Comoglio e Dogus M. Altintas. "MET∆14 promotes a ligand-dependent, AKT-driven invasive growth". Life Science Alliance 5, n. 10 (30 maggio 2022): e202201409. http://dx.doi.org/10.26508/lsa.202201409.
Uzumcu, Mehmet, Zui Pan, Yi Chu, Peter E. Kuhn e Rob Zachow. "Immunolocalization of the hepatocyte growth factor (HGF) system in the rat ovary and the anti-apoptotic effect of HGF in rat ovarian granulosa cells in vitro". Reproduction 132, n. 2 (agosto 2006): 291–99. http://dx.doi.org/10.1530/rep.1.00989.
Miranda, Oshin, Mariya Farooqui e Jill Siegfried. "Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer". Cancers 10, n. 9 (21 agosto 2018): 280. http://dx.doi.org/10.3390/cancers10090280.
Kempe, Sabrina. "MET-Inhibitoren sperren Ausweichroute über HGF/c-MET-Signalweg". Im Fokus Onkologie 25, n. 2 (aprile 2022): 29–33. http://dx.doi.org/10.1007/s15015-022-3829-8.
Ricci, G., A. Catizone e M. Galdieri. "Expression and functional role of hepatocyte growth factor and its receptor (c-met) during fetal mouse testis development". Journal of Endocrinology 191, n. 3 (dicembre 2006): 559–70. http://dx.doi.org/10.1677/joe.1.06879.
Buchynska, L. G., O. V. Brieieva e S. V. Nespriadko. "EXPRESSION OF HEPATOCYTE GROWTH FACTOR AND C-MET RECEPTOR IN STROMAL FIBROBLASTS AND TUMOR CELLS OF ENDOMETRIAL CARCINOMA". Experimental Oncology 45, n. 1 (2023): 79–87. http://dx.doi.org/10.15407/exp-oncology.2023.01.079.
Xu, Chuanhui, Anke Van Den Berg, Arjan Diepstra, Miao Wang, Debora Jong, Hans JTWM Vos, Peter Moller, Sibrand Poppema e Lydia Visser. "The HGF/c-Met Signaling Pathway in Hodgkin Lymphoma." Blood 114, n. 22 (20 novembre 2009): 1551. http://dx.doi.org/10.1182/blood.v114.22.1551.1551.
Elliott, Bruce E., Wesley L. Hung, Alexander H. Boag e Alan B. Tuck. "The role of hepatocyte growth factor (scatter factor) in epithelialmesenchymal transition and breast cancer". Canadian Journal of Physiology and Pharmacology 80, n. 2 (1 febbraio 2002): 91–102. http://dx.doi.org/10.1139/y02-010.
Tsubaki, Masanobu, Shiori Seki, Tomoya Takeda, Akiko Chihara, Yuuko Arai, Yuusuke Morii, Motohiro Imano, Takao Satou, Kazunori Shimomura e Shozo Nishida. "The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells". International Journal of Molecular Sciences 21, n. 21 (24 ottobre 2020): 7905. http://dx.doi.org/10.3390/ijms21217905.
Chattopadhyay, Naibedya, R. J. MacLeod, Jacob Tfelt-Hansen e Edward M. Brown. "1α,25(OH)2-vitamin D3inhibits HGF synthesis and secretion from MG-63 human osteosarcoma cells". American Journal of Physiology-Endocrinology and Metabolism 284, n. 1 (1 gennaio 2003): E219—E227. http://dx.doi.org/10.1152/ajpendo.00247.2002.
UMITSU, Masataka, e Junichi TAKAGI. "Structural basis of HGF-Met signaling". Japanese Journal of Thrombosis and Hemostasis 27, n. 1 (2016): 77–84. http://dx.doi.org/10.2491/jjsth.27.77.
Zhou, Hong, Yuen Pon e Alice Wong. "HGF/MET Signaling in Ovarian Cancer". Current Molecular Medicine 8, n. 6 (1 settembre 2008): 469–80. http://dx.doi.org/10.2174/156652408785747933.
Jalili, Ali, Neeta Shirvaikar, Sara Ilnitsky, A. Robert Turner, Mariusz Z. Ratajczak e Anna Janowska-Wieczorek. "G-CSF Induces Expression of Both Hepatocyte Growth Factor (HGF) and Its Receptor (c-Met) in Human Hematopoietic Stem/Progenitor Cells and Mature Myeloid Cells - Novel Evidence That during Mobilization the HGF-c-Met Axis Counterbalances G-CSF-Induced Attenuation of the SDF-1-CXCR4 Axis." Blood 110, n. 11 (16 novembre 2007): 2203. http://dx.doi.org/10.1182/blood.v110.11.2203.2203.
Liu, Y., E. M. Tolbert, A. M. Sun e L. D. Dworkin. "Primary structure of rat HGF receptor and induced expression in glomerular mesangial cells". American Journal of Physiology-Renal Physiology 271, n. 3 (1 settembre 1996): F679—F688. http://dx.doi.org/10.1152/ajprenal.1996.271.3.f679.
Zachow, Rob, e Mehmet Uzumcu. "The hepatocyte growth factor system as a regulator of female and male gonadal function". Journal of Endocrinology 195, n. 3 (13 settembre 2007): 359–71. http://dx.doi.org/10.1677/joe-07-0466.